Paper33178201
Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches.
Klein K and 12 others. Front Immunol, 2020. Cited by 98 papers, by iCite.
Cite this record
ConductScience Library. Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches. Papers, record 33178201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33178201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Energy Metabolism | Major topic |
| Mitochondria | Major topic |
| Neoplasms | Major topic |
| Tumor Escape | Major topic |
| Animals | |
| Humans | |
| Immune Checkpoint Inhibitors | |
| Immunotherapy, Adoptive | |
| Lymphocytes, Tumor-Infiltrating | |
| Molecular Targeted Therapy | |
| Signal Transduction | |
| T-Lymphocytes | |
| Tumor Hypoxia | |
| Tumor Microenvironment | |
| Tumor-Associated Macrophages |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 CA016672 | NCI NIH HHS | United States | P30CA016672 | PubMed and NIH |
Source NIH RePORTER
References98
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31076448 | Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy. | Blood | 2019 | https://conductscience.org/library/papers/31076448 | PubMed |
| 2 | 32265936 | Metabolic Reprograming of Microglia in the Regulation of the Innate Inflammatory Response. | Front Immunol | 2020 | https://conductscience.org/library/papers/32265936 | PubMed |
| 3 | 27496732 | The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction. | Immunity | 2016 | https://conductscience.org/library/papers/27496732 | PubMed |
| 4 | 25119024 | Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. | Nature | 2014 | https://conductscience.org/library/papers/25119024 | PubMed |
| 5 | 28810896 | Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism. | J Exp Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28810896 | PubMed |
| 6 | 26321679 | Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. | Cell | 2015 | https://conductscience.org/library/papers/26321679 | PubMed |
| 7 | 25150637 | AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells. | Radiother Oncol | 2014 | https://conductscience.org/library/papers/25150637 | PubMed |
| 8 | 30144423 | Targeting mitochondria in cancer: current concepts and immunotherapy approaches. | Transl Res | 2018 | https://conductscience.org/library/papers/30144423 | PubMed |
| 9 | 31486833 | Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial. | JAMA Oncol | 2019 | https://conductscience.org/library/papers/31486833 | PubMed |
| 10 | 25007226 | Reprogramming of tumor metabolism by targeting mitochondria improves tumor response to irradiation. | Acta Oncol | 2015 | https://conductscience.org/library/papers/25007226 | PubMed |
| 11 | 31439581 | A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31439581 | PubMed |
| 12 | 25809635 | PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. | Nat Commun | 2015 | https://conductscience.org/library/papers/25809635 | PubMed |
| 13 | 30619380 | Editorial: Metabolism of Cancer Cells and Immune Cells in the Tumor Microenvironment. | Front Immunol | 2018 | https://conductscience.org/library/papers/30619380 | PubMed |
| 14 | 20467424 | Targeting mitochondria for cancer therapy. | Nat Rev Drug Discov | 2010 | https://conductscience.org/library/papers/20467424 | PubMed |
| 15 | 29420223 | Oxidative Phosphorylation as an Emerging Target in Cancer Therapy. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/29420223 | PubMed |
| 16 | 19543266 | mTOR regulates memory CD8 T-cell differentiation. | Nature | 2009 | https://conductscience.org/library/papers/19543266 | PubMed |
| 17 | 22134189 | Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue. | Cell Cycle | 2011 | https://conductscience.org/library/papers/22134189 | PubMed |
| 18 | 20518702 | High-glucose stimulation increases reactive oxygen species production through the calcium and mitogen-activated protein kinase-mediated activation of mitochondrial fission. | Antioxid Redox Signal | 2011 | https://conductscience.org/library/papers/20518702 | PubMed |
| 19 | 30201710 | Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30201710 | PubMed |
| 20 | 27547291 | Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment. | Oxid Med Cell Longev | 2016 | https://conductscience.org/library/papers/27547291 | PubMed |
Cited by80
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953687 | Benchmarking Machine Learning and Automated Image Analysis for Organelle Quantification. | Chem Biomed Imaging | 2026 | https://conductscience.org/library/papers/42953687 | PubMed |
| 42326013 | Tumor-immune metabolic tug-of-war: from immune escape to targeting metabolic rewiring in cancer therapy. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42326013 | PubMed |
| 42255224 | Intercellular mitochondrial transfer in melanoma progression and therapeutic resistance: mechanisms and targeting potential. | Front Oncol | 2026 | https://conductscience.org/library/papers/42255224 | PubMed |
| 42193900 | Mitochondrial Stress Orchestrates Tumor Immune Evasion and Immunotherapy Resistance. | Cells | 2026 | https://conductscience.org/library/papers/42193900 | PubMed |
| 42121899 | Cardiolipin Induces CXCL9/CXCL10 Expression in Tumor-Infiltrating Lymphocytes. | Cells | 2026 | https://conductscience.org/library/papers/42121899 | PubMed |
| 42051151 | RNA binding protein ZFP36L1 promotes ferroptosis in chronic rhinosinusitis by destabilizing CAMK2A mRNA and impairing mitochondrial quality control. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42051151 | PubMed |
| 41892308 | Mitochondrial Quality Control and Metabolic Reprogramming in Hepatocellular Carcinoma: Implications for Immunotherapy and Treatment Resistance. | Cells | 2026 | https://conductscience.org/library/papers/41892308 | PubMed |
| 41639740 | Mitochondrial DNA mutations and intercellular mitochondrial transfer in cancer: mechanisms, biological effects, and clinical potential. | Biomark Res | 2026 | https://conductscience.org/library/papers/41639740 | PubMed |
| 41311372 | Emerging hallmarks and the rise of complexities and heterogeneity of tumor. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/41311372 | PubMed |
| 41282600 | Mitochondrial involvement in PC: improving therapeutic strategies. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41282600 | PubMed |
| 41233441 | Effects of ultra-fast nanosecond electric pulses on mitochondria transmembrane potential and oxidation. | Sci Rep | 2025 | https://conductscience.org/library/papers/41233441 | PubMed |
| 41151861 | Verbascoside Suppresses Epithelial-Mesenchymal Transition and Mitochondrial Biogenesis by Targeting Anti-senescence Signaling in Castration-resistant Prostate Cancer. | Cancer Genomics Proteomics | 2025 | https://conductscience.org/library/papers/41151861 | PubMed |
| 41151855 | Rutin Suppresses EMT and Induces Mitochondrial Biogenesis via ER Stress-linked AMPK/SIRT1 Signaling in Prostate Cancer Cells. | Cancer Genomics Proteomics | 2025 | https://conductscience.org/library/papers/41151855 | PubMed |
| 41118021 | Expressions, immune associations, and prognostic values of mitochondrial ribosomal protein MRPL3 in the pan cancer landscape. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41118021 | PubMed |
| 41102967 | Mitochondria-Targeted Nanoformulations: New Therapeutic Strategies and Opportunities for Cancer Immunotherapy. | Curr Drug Targets | 2026 | https://conductscience.org/library/papers/41102967 | PubMed |
| 41102706 | Targeting mitochondrial transporters and metabolic reprogramming for disease treatment. | J Transl Med | 2025 | https://conductscience.org/library/papers/41102706 | PubMed |
| 41083278 | Mitochondrial dysfunction alters early endosome trafficking via microtubule reorganization. | Life Sci Alliance | 2026 | https://conductscience.org/library/papers/41083278 | PubMed |
| 41008599 | The Emerging Role of Mitochondrial Dysfunction in Thyroid Cancer: Mediating Tumor Progression, Drug Resistance, and Reshaping of the Immune Microenvironment. | Biomolecules | 2025 | https://conductscience.org/library/papers/41008599 | PubMed |
| 40715697 | Rewiring cancer metabolism: oncogenic signaling pathways and targeted therapeutics. | Sci China Life Sci | 2025 | https://conductscience.org/library/papers/40715697 | PubMed |
| 40697926 | Constructing a novel mitochondrial metabolism-related genes signature to evaluate tumor immune microenvironment and predict survival of colorectal cancer. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40697926 | PubMed |
Genes39
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33178201
GET https://conductscience.org/api/papers/v1/33178201/references?page=2